{"product_id":"tirsema-44-tirzepatide-40mg-semaglutide-4mg-combination-pen","title":"HD Lab Tirsema 44 | Tirzepatide 40mg + Semaglutide 4mg Combination Pen","description":"\u003cp class=\"font-claude-response-body break-words whitespace-normal\" dir=\"ltr\"\u003eTirsema 44 is a pre-filled, multi-dose subcutaneous injection pen combining two GLP-1 receptor-active compounds — tirzepatide (40mg) and semaglutide (4mg) — in a single solution. Manufactured by HD Labs, the pen is intended for laboratory research applications by qualified institutions studying incretin receptor pathways.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal\" dir=\"ltr\"\u003e\u003cstrong\u003eImportant:\u003c\/strong\u003e this is a co-formulated blend of two distinct compounds. There is currently no published clinical research evaluating tirzepatide and semaglutide combined in a single formulation — existing research on each compound has studied them individually or compared them head-to-head, not combined. This listing describes the product's composition only; it does not imply any established safety, efficacy, or research basis for the combination itself.\u003c\/p\u003e","brand":"Health Tech","offers":[{"title":"Default Title","offer_id":48818649104609,"sku":null,"price":2580.0,"currency_code":"ZAR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0825\/1935\/9713\/files\/c51dc227-acc4-4ac5-9efb-b7af524de284.png?v=1785242060","url":"https:\/\/health-tech.co.za\/products\/tirsema-44-tirzepatide-40mg-semaglutide-4mg-combination-pen","provider":"Health Tech","version":"1.0","type":"link"}